Reply to Adzemovic et al.
作者信息
Randall Philippa, Mutsvangwa Junior, Nliwasa Marriott, Wilson Lindsay, Reyneke Brandon, Makamure Beauty, Makambwa Edson, Meldau Richard, Dheda Keertan, Munyati Shungu, Siddiqi Omar, Corbett Elizabeth, Esmail Ali
机构信息
Centre for Lung Infection and Immunity, Department of Medicine, University of Cape Town, Observatory, Cape Town, South Africa.
Division of Pulmonology, University of Cape Town Lung Institute, Observatory, Cape Town, South Africa.
出版信息
Open Forum Infect Dis. 2025 May 5;12(5):ofaf271. doi: 10.1093/ofid/ofaf271. eCollection 2025 May.
Abstract
摘要
相似文献
1
Reply to Adzemovic et al.
Open Forum Infect Dis. 2025 May 5;12(5):ofaf271. doi: 10.1093/ofid/ofaf271. eCollection 2025 May.
2
Reply to Chen et al, Uchikoba et al, Siberry et al, and Vuorio et al.
Clin Infect Dis. 2022 Dec 19;75(12):2282-2283. doi: 10.1093/cid/ciac668.
3
Reply to Garnemark et al. The Swedish National Formulary for Children ePed. Comment on "Shaniv et al. A Callout for International Collaboration. Reply to Giger, E.V.; Tilen, R. Comment on "Shaniv et al. Neonatal Drug Formularies-A Global Scope. 2023, , 848". 2023, , 1803".
Children (Basel). 2024 Oct 31;11(11):1341. doi: 10.3390/children11111341.
4
Cryobiopsy Compared with Surgical Lung Biopsy in ILD: Reply to Maldonado , Froidure , Bendstrup , Agarwal , Richeldi , Rajchgot , and Quadrelli .
Am J Respir Crit Care Med. 2019 Oct 1;200(7):944-946. doi: 10.1164/rccm.201906-1252LE.
5
Reply to D.C. Sgroi et al, T. Sanft et al, M.S. Copur et al, and M.P. Goetz et al.
J Clin Oncol. 2016 Nov 10;34(32):3946-3948. doi: 10.1200/JCO.2016.68.7020.
6
Reply to A.C. Olson et al, R.T. Dess et al, D.D. Yang et al, and R.J. Brenneman et al.
J Clin Oncol. 2021 Sep 1;39(25):2848-2849. doi: 10.1200/JCO.21.00810. Epub 2021 Jun 4.
7
Reply to J.A. Vargo et al, H.J.A. Adams et al, E. Hindié et al, and S. Kothari et al.
J Clin Oncol. 2017 Aug 20;35(24):2853-2854. doi: 10.1200/JCO.2017.74.0068. Epub 2017 Jul 6.
8
Reply to J.A. Vargo et al, H.J.A. Adams et al, E. Hindié et al, and S. Kothari et al.
J Clin Oncol. 2017 Aug 20;35(24):2854-2855. doi: 10.1200/JCO.2017.74.0076. Epub 2017 Jul 6.
9
Reply to A. Piccardo et al, E. Hindié et al, M.C. Kreissl et al, M. Doss, J. Buscombe, R. Fisher, M. Sollini et al, M. Lichtenstein, and M. Tulchinsky et al.
J Clin Oncol. 2018 Jun 20;36(18):1889-1892. doi: 10.1200/JCO.2018.78.4074. Epub 2018 May 3.
10
Reply by Gattinoni to Hedenstierna , to Maley , to Fowler , to Bhatia and Mohammed, to Bos, to Koumbourlis and Motoyama, and to Haouzi .
Am J Respir Crit Care Med. 2020 Aug 15;202(4):628-630. doi: 10.1164/rccm.202004-1052LE.
本文引用的文献
1
Utility of Cerebrospinal Fluid Unstimulated Interferon-Gamma (IRISA-TB) as a Same-Day Test for Tuberculous Meningitis in a Tuberculosis-Endemic, Resource-Poor Setting.
Open Forum Infect Dis. 2024 Aug 29;11(9):ofae496. doi: 10.1093/ofid/ofae496. eCollection 2024 Sep.
2
Prevalence, incidence, and case fatality of tuberculous meningitis in adults living with HIV: a systematic review and meta-analysis.
BMC Public Health. 2024 Aug 7;24(1):2145. doi: 10.1186/s12889-024-19683-4.
3
Yield of Facility-based Targeted Universal Testing for Tuberculosis With Xpert and Mycobacterial Culture in High-Risk Groups Attending Primary Care Facilities in South Africa.
Clin Infect Dis. 2023 May 3;76(9):1594-1603. doi: 10.1093/cid/ciac965.
4
Comparative Analytical Evaluation of Four Centralized Platforms for the Detection of Mycobacterium tuberculosis Complex and Resistance to Rifampicin and Isoniazid.
J Clin Microbiol. 2021 Feb 18;59(3). doi: 10.1128/JCM.02168-20.
5
Inadequate diagnostics: the case to move beyond the bacilli for detection of meningitis due to Mycobacterium tuberculosis.
J Med Microbiol. 2019 May;68(5):755-760. doi: 10.1099/jmm.0.000975. Epub 2019 Apr 17.
6
Utility of the T-SPOT.TB test's borderline category to increase test resolution for results around the cut-off point.
Tuberculosis (Edinb). 2018 Jan;108:178-185. doi: 10.1016/j.tube.2017.12.005. Epub 2017 Dec 18.
7
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.
Lancet Infect Dis. 2018 Jan;18(1):76-84. doi: 10.1016/S1473-3099(17)30691-6. Epub 2017 Nov 30.
8
Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?
Clin Infect Dis. 2016 Apr 15;62(8):995-1001. doi: 10.1093/cid/civ1223. Epub 2016 Feb 16.
9
Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing.
Am J Respir Crit Care Med. 2009 Jul 1;180(1):49-58. doi: 10.1164/rccm.200811-1704OC. Epub 2009 Apr 2.
Zotero 插件